^“Tyk2 negatively regulates adaptive Th1 immunity by mediating IL-10 signaling and promoting IFN-gamma-dependent IL-10 reactivation”. Journal of Immunology176 (12): 7263–7271. (June 2006). doi:10.4049/jimmunol.176.12.7263. PMID16751369.
^ ab“Tyk2 plays a restricted role in IFN alpha signaling, although it is required for IL-12-mediated T cell function”. Immunity13 (4): 561–571. (October 2000). doi:10.1016/S1074-7613(00)00055-8. PMID11070174.
^“Central role for type I interferons and Tyk2 in lipopolysaccharide-induced endotoxin shock”. Nature Immunology4 (5): 471–477. (May 2003). doi:10.1038/ni910. PMID12679810.
^“Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity”. Immunity25 (5): 745–755. (November 2006). doi:10.1016/j.immuni.2006.09.009. PMID17088085.
^“Hyperimmunoglobulin E syndrome and tyrosine kinase 2 deficiency”. Current Opinion in Allergy and Clinical Immunology7 (6): 506–509. (December 2007). doi:10.1097/ACI.0b013e3282f1baea. PMID17989526.
^“Interaction of p59fyn with interferon-activated Jak kinases”. Biochemical and Biophysical Research Communications235 (1): 83–88. (June 1997). doi:10.1006/bbrc.1997.6741. PMID9196040.
^“Association of the interferon-dependent tyrosine kinase Tyk-2 with the hematopoietic cell phosphatase”. The Journal of Biological Chemistry270 (31): 18179–18182. (August 1995). doi:10.1074/jbc.270.31.18179. PMID7629131.
^“Specific contribution of Tyk2 JH regions to the binding and the expression of the interferon alpha/beta receptor component IFNAR1”. The Journal of Biological Chemistry273 (38): 24723–24729. (September 1998). doi:10.1074/jbc.273.38.24723. PMID9733772.
^“Interferon-alpha signaling promotes nucleus-to-cytoplasmic redistribution of p95Vav, and formation of a multisubunit complex involving Vav, Ku80, and Tyk2”. Biochemical and Biophysical Research Communications267 (3): 692–696. (January 2000). doi:10.1006/bbrc.1999.1978. PMID10673353.
^“The WD motif-containing protein RACK-1 functions as a scaffold protein within the type I IFN receptor-signaling complex”. Journal of Immunology171 (6): 2989–2994. (September 2003). doi:10.4049/jimmunol.171.6.2989. PMID12960323.
“Colony-stimulating factor 1-induced STAT1 and STAT3 activation is accompanied by phosphorylation of Tyk2 in macrophages and Tyk2 and JAK1 in fibroblasts”. Blood86 (8): 2948–2956. (October 1995). doi:10.1182/blood.V86.8.2948.2948. PMID7579387.
“Homodimerization and intermolecular tyrosine phosphorylation of the Tyk-2 tyrosine kinase”. FEBS Letters374 (3): 317–322. (November 1995). doi:10.1016/0014-5793(95)01094-U. PMID7589562.
“Association of the interferon-dependent tyrosine kinase Tyk-2 with the hematopoietic cell phosphatase”. The Journal of Biological Chemistry270 (31): 18179–18182. (August 1995). doi:10.1074/jbc.270.31.18179. PMID7629131.
“Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides”. Gene138 (1–2): 171–174. (January 1994). doi:10.1016/0378-1119(94)90802-8. PMID8125298.
“The type I interferon receptor mediates tyrosine phosphorylation of insulin receptor substrate 2”. The Journal of Biological Chemistry271 (1): 278–282. (January 1996). doi:10.1074/jbc.271.1.278. PMID8550573.
“Interferon-alpha-dependent activation of Tyk2 requires phosphorylation of positive regulatory tyrosines by another kinase”. The Journal of Biological Chemistry271 (34): 20494–20500. (August 1996). doi:10.1074/jbc.271.34.20494. PMID8702790.
“Interaction of the c-cbl proto-oncogene product with the Tyk-2 protein tyrosine kinase”. Biochemical and Biophysical Research Communications225 (3): 833–838. (August 1996). doi:10.1006/bbrc.1996.1259. PMID8780698.
“Differential associations between the cytoplasmic regions of the interleukin-12 receptor subunits beta1 and beta2 and JAK kinases”. The Journal of Biological Chemistry272 (9): 6073–6077. (February 1997). doi:10.1074/jbc.272.9.6073. PMID9038232.
“Thrombopoietin and thrombin induce tyrosine phosphorylation of Vav in human blood platelets”. Blood89 (8): 2789–2798. (April 1997). doi:10.1182/blood.V89.8.2789. PMID9108397.
“Interaction of p59fyn with interferon-activated Jak kinases”. Biochemical and Biophysical Research Communications235 (1): 83–88. (June 1997). doi:10.1006/bbrc.1997.6741. PMID9196040.
“Janus kinase-dependent activation of insulin receptor substrate 1 in response to interleukin-4, oncostatin M, and the interferons”. The Journal of Biological Chemistry272 (39): 24183–24190. (September 1997). doi:10.1074/jbc.272.39.24183. PMID9305869.
“Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library”. Gene200 (1–2): 149–156. (October 1997). doi:10.1016/S0378-1119(97)00411-3. PMID9373149.
“The type I interferon receptor mediates tyrosine phosphorylation of the CrkL adaptor protein”. The Journal of Biological Chemistry272 (48): 29991–29994. (November 1997). doi:10.1074/jbc.272.48.29991. PMID9374471.